Anzeige
Meldung des Tages: Staatlich gefördert – Startet hier Kanadas nächster Lithium-Champion?

Curatis News

Aktie
WKN:  A40BDL ISIN:  CH1330780979 Branche:  Pharmazeutika Land:  Schweiz
17,60 CHF
-1,10 CHF
-5,88%
19,383 € 17:36:34 Uhr
Depot/Watchlist
Marktkapitalisierung *
59,05 Mio. €
Streubesitz
22,26%
KGV
-14,67
Index-Zuordnung
-

Curatis News

21.11.25 - EQS
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor
Curatis Holding AG / Key word(s): Agreement/Financing Curatis Holding AG announces CHF 1.2 million private placement with strategic investor 21-Nov-2025 / 07:00 CET/CEST ...
18.09.25 - EQS
FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
Curatis Holding AG / Key word(s): Miscellaneous FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3 18.09.2025 / 07:00 ...
15.09.25 - EQS
Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01
Curatis Holding AG / Key word(s): Half Year Results Curatis: Double-​digit growth in core business and development milestone achieved for C-PTBE-01 15-Sep-2025 / 07:00 ...
05.09.25 - EQS
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG / Key word(s): Agreement/Incoming Orders Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues 05.09.2025 / ...
31.07.25 - EQS
FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
Curatis Holding AG / Key word(s): Legal Matter/Strategic Company Decision FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study 31.07.2025 / 06:00 CET/CEST
24.05.25 - EQS
Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Curatis Holding AG / Key word(s): AGMEGM Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors 24.05.2025 / 11:31 CET/CEST
23.05.25 - EQS
Curatis discloses Corticorelin as active substance of C-PTBE-01 | Market Opportunity in PTBE expected to exceed USD 1 billion | Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog
Curatis Holding AG / Key word(s): Change in Forecast/Strategic Company Decision Curatis discloses Corticorelin as active substance of C-PTBE-01 | Market Opportunity in PTBE ex...
27.03.25 - EQS
Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe beim Lead-Projekt C-PTBE-01
Curatis Holding AG / Key word(s): Annual Results/Strategic Company Decision Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe ...
11.03.25 - EQS
Curatis Announces Formation of Distinguished Advisory Board
Curatis Holding AG / Key word(s): Strategic Company Decision Curatis Announces Formation of Distinguished Advisory Board 11.03.2025 / 07:00 CET/CEST
14.11.24 - EQS
Curatis wird für C-PTBE-01 in den USA eine Biologic License beantragen - damit erhöht sich die Dauer des Marktschutzes in den USA markant im Falle einer Zulassung
Curatis Holding AG / Key word(s): Strategic Company Decision Curatis wird für C-PTBE-01 in den USA eine Biologic License beantragen - damit erhöht sich die Dauer des ...
16.09.24 - EQS
Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs
Curatis Holding AG / Key word(s): Half Year Results Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-​Pipeline auf Kurs 16-Sep-2024 / 07:00 ...
12.09.24 - EQS
Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September
Curatis Holding AG / Key word(s): Miscellaneous Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September 12.09.2024 ...
27.08.24 - EQS
Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA
Curatis Holding AG / Key word(s): Expansion/Strategic Company Decision Curatis auf Kurs: Einreichung des Antrags für Orphan-​Drug-Designation des wichtigsten ...
25.07.24 - EQS
Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB
Curatis Holding AG / Key word(s): Research Update Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB 25.07.2024 / 07:00 ...
21.06.24 - EQS
Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Curatis Holding AG / Key word(s): AGMEGM Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors 21.06.2024 / 17:13 CET/CEST
24.05.24 - EQS
Curatis Holding AG publishes Annual Report of the (then still named) Kinarus Group for FY2023 and announces appointment of Chief Financial Officer
Curatis Holding AG / Key word(s): Annual Results/Personnel Curatis Holding AG publishes Annual Report of the (then still named) Kinarus Group for FY2023 and announces ...

Newssuche

Videos

newspaper
08:20 Uhr
2026 03 02 23 15 NEWSTRADING im März
Nur noch 12 Plätze für Top Newstrading Seminar am 8.3.! Infos zu den Strategien und Anmeldung unter ... Mehr »